BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update

BioNexus Gene Lab Corp. (NASDAQ:BGLC) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 157,300 shares, a growth of 206.0% from the August 31st total of 51,400 shares. Currently, 12.4% of the shares of the stock are sold short. Based on an average trading volume of 1,980,000 shares, the short-interest ratio is presently 0.1 days. Based on an average trading volume of 1,980,000 shares, the short-interest ratio is presently 0.1 days. Currently, 12.4% of the shares of the stock are sold short.

BioNexus Gene Lab Price Performance

NASDAQ:BGLC opened at $5.36 on Friday. BioNexus Gene Lab has a 12-month low of $2.01 and a 12-month high of $15.60. The firm has a 50-day moving average price of $5.50 and a 200 day moving average price of $4.14.

BioNexus Gene Lab (NASDAQ:BGLC) last released its quarterly earnings data on Monday, August 18th. The company reported ($0.34) earnings per share for the quarter. BioNexus Gene Lab had a negative net margin of 30.70% and a negative return on equity of 35.54%. The company had revenue of $2.26 million for the quarter.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.